Irofulven Compared With Fluorouracil in Treating Patients With Pancreatic Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. It is not yet known whether irofulven is effective in treating
pancreatic cancer.
PURPOSE: Randomized phase III trial to compare the effectiveness of irofulven with that of
fluorouracil in treating patients who have locally advanced or metastatic pancreatic cancer
that has not responded to previous treatment with gemcitabine.